Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance

Malaria Journal

Volumn 6, Issue , 2007, Pages

  Alexander, Neal ^a   Sutherland, Colin ^a   Roper, Cally ^a   Cissé, Badara ^a,b   Schellenberg, David ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; FANSIDAR;

ADOLESCENT; AGE SPECIFIC CARE; AGED; ARTICLE; CHILD; DISEASE DURATION; GENETIC SELECTION; HUMAN; INFECTION CONTROL; MALARIA; MALARIA CONTROL; MATHEMATICAL MODEL; PLASMODIUM; PREDICTION; RURAL AREA; SENEGAL; SIMULATION; TANZANIA;

AGE FACTORS; ANIMALS; ANTIMALARIALS; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA; MODELS, BIOLOGICAL; PLASMODIUM; RURAL POPULATION; SELECTION, GENETIC; SENEGAL; TANZANIA;

EID: 33847046025     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-6-9     Document Type: Article

References (25)

1. The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas. B Greenwood, Am J Trop Med Hyg 2004 70 1 1 7 14971690
2. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. D Schellenberg C Menendez E Kahigwa JJ Aponte J Vidal M Tanner H Mshinda P Alonso, Lancet 2001 357 9267 1471 1477 10.1016/S0140-6736(00)04643-2 11377597
3. Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial. JJ Massaga AY Kitua MM Lemnge JA Akida LN Malle AM Ronn TG Theander IC Bygbjerg, Lancet 2003 361 9372 1853 1860 10.1016/S0140-6736(03)13504-0 12788572
4. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. D Chandramohan S Owusu-Agyei I Carneiro T Awine K Amponsa-Achiano N Mensah S Jaffar R Baiden A Hodgson F Binka B Greenwood, BMJ 2005 331 7519 727 733 16195288 10.1136/bmj.331.7519.727
5. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in mozambican infants: a randomized, placebo-controlled trial. E Macete P Aide JJ Aponte S Sanz I Mandomando M Espasa B Sigauque C Dobano S Mabunda M Dgedge P Alonso C Menendez, J Infect Dis 2006 194 3 276 285 10.1086/505431 16826474
6. Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine. F Marks V von Kalckreuth R Kobbe S Adjei O Adjei RD Horstmann CG Meyer J May, J Infect Dis 2005 192 11 1962 1965 10.1086/497698 16267768
7. The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi). W Prudhomme O'Meara JG Breman FE McKenzie, Malar J 2005 4 33 16033653 10.1186/1475-2875-4-33
8. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine prevents malaria in Senegalese children. B Cissé C Sokhna D Boulanger J Milet EH Bâ K Richardson R Hallett C Sutherland K Simondon F Simondon N Alexander O Gaye G Targett J Lines B Greenwood JF Trape, Lancet 2006 367 659 667 10.1016/S0140-6736(06)68264-0 16503464
9. The evolution of drug-resistant malaria: the role of drug elimination half-life. IM Hastings WM Watkins NJ White, Philos Trans R Soc Lond B Biol Sci 2002 357 1420 505 519 10.1098/rstb.2001.1036 12028788
10. Epidemiological models for the spread of anti-malarial resistance. JC Koella R Antia, Malar J 2003 2 3 12643812 10.1186/1475-2875-2-3
11. The search for effective and sustainable treatments for Plasmodium falciparum malaria in Africa: a model of the selection of resistance by antifolate drugs and their combinations. WM Watkins CH Sibley IM Hastings, Am J Trop Med Hyg 2005 72 2 163 173 15741553
12. Models in Biology: Mathematics, Statistics and Computing. D Brown P Rothery, Chichester, John Wiley and Sons 1993 9061961
13. Multigenic drug resistance among inbred malaria parasites. C Dye BG Williams, Proc Biol Sci 1997 264 1378 61 67 10.1098/rspb.1997.0009 10365399
14. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. C Roper R Pearce B Bredenkamp J Gumede C Drakeley F Mosha D Chandramohan B Sharp, Lancet 2003 361 9364 1174 1181 10.1016/S0140-6736(03)12951-0 12686039
15. Inequities among the very poor: health care for children in rural southern Tanzania. J Armstrong Schellenberg CG Victora A Mushi D de Savigny D Schellenberg H Mshinda J Bryce, Lancet 2003 361 9357 561 566 10.1016/S0140-6736(03)12515-9 12598141
16. Diagnostic accuracy and case management of clinical malaria in the primary health services of a rural area in south-eastern Tanzania. F Font M Alonso González R Nathan J Kimario F Lwilla C Ascaso M Tanner C Menéndez PL Alonso, Trop Med Int Health 2001 6 6 423 428 10.1046/j.1365-3156.2001.00727.x 11422955
17. Drug resistance models for malaria. MJ Mackinnon, Acta Trop 2005 94 3 207 217 15894181
18. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. S Krishna NJ White, Clinical Pharmacokinetics 1996 30 4 263 299 8983859
19. Antimalarial drug resistance and combination chemotherapy. N White, Philos Trans R Soc Lond B Biol Sci 1999 354 1384 739 749 10.1098/rstb.1999.0426 10365399
20. Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. W Prudhomme O'Meara DL Smith FE McKenzie, PLoS Med 2006 3 5 e141 16573365 10.1371/journal.pmed.0030141
21. Altitude-dependent and -independent variations in Plasmodium falciparum prevalence in northeastern Tanzania. CJ Drakeley I Carneiro H Reyburn R Malima JP Lusingu J Cox TG Theander WM Nkya MM Lemnge EM Riley, J Infect Dis 2005 191 10 1589 1598 10.1086/429669 15838785
22. Mapping drug resistance genes in Plasmodium falciparum by genome-wide association. TJ Anderson, Curr Drug Targets Infect Disord 2004 4 1 65 78 10.2174/1568005043480943 15032635
23. How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy. SED Nsimba, J Ethnobiol Ethnomedicine 2006 2 1 5 16403225 10.1186/1746-4269-2-5
24. The origins and spread of antimalarial drug resistance: lessons for policy makers. TJ Anderson C Roper, Acta Trop 2005 94 3 269 280 15878153
25. Intermittent presumptive treatment for malaria. NJ White, PLoS Med 2005 2 1 e3 15696210 10.1371/journal.pmed.0020003